Lenacapavir: A Breakthrough in HIV Prevention Lenacapavir, marketed as Yeytuo, has advanced HIV prevention by offering a long-acting injectable PrEP treatment. Unlike daily pills, it is given as an injection twice a year, a feature that could simplify adherence for many people at risk. In the European Union, lenacapavir has been approved as a preventive…